COVID-19 Funding Opportunities
The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.
Internal deadline: September 7, 2021
This announcement encourages Collaborative Program
Grant applications that propose to conduct research to address complex
and challenging biomedical problems, important for the mission
of the National Institute of General Medical Sciences (NIGMS), through
deeply integrated, multidisciplinary research teams. The Grant is designed
to support research in which funding a team of interdependent investigators
offers significant advantages over support of individual research project
grants. Applications should address critical issues and be sufficiently
challenging, ambitious, and innovative that objectives could not be
achieved by individual investigators. Applications may address any area
of science within the NIGMS mission, which is to support basic research
that increases understanding of biological processes at a range of levels,
from molecules and cells to tissues, whole organisms and populations.
Eligibility & Requirements:
Consultation with relevant staff at least 10 weeks
prior to the application due date is strongly encouraged.
Internal Nomination Process:
Application submission deadline: September 15, 2021
The Johns Hopkins University School of Medicine announces a request for applications for the inaugural Merkin Peripheral Neuropathy and Nerve Regeneration (PNNR) Center award cycle. The discovery fund award program is designed to attract and support young investigators focused on increasing our understanding of the disease with the ultimate goal of finding new treatment options for peripheral neuropathies and nerve injuries.
This announcement seeks proposals for high-risk, high-reward pilot projects led by junior faculty or senior post-doctoral fellow of the school of medicine. Merkin PNNR Center will award several projects for maximum $50,000/year lasting up to two years depending on the scope of the proposed project. Novelty of the proposed ideas as well as likelihood for successful transitioning to external funding will be the key selection criteria for funding. Duplicate or overlapping funding from any other private or public source for the same project is not allowed. The award recipient or a designee is required to attend the monthly Grant Holders' meeting during the award period. Attendance at minimum 8/12 meetings/year is required to continue to receive funding.
Timeline: Submission deadline by Sep 15, the award announcement by Oct 15 with the expected project start date by Nov 1.
Application package (downloadable from
the Merkin PNNR Center website):
Application deadline: September 20, 2021
and PROPEL Awards are designed to accelerate protocols to produce
efficient, high-quality, safe and disseminatable research. These clinical
research grants award ICTR
Clinical Research Unit resources to investigators based on merit
and willingness to be actively monitored by the Translational Research
Evaluation Committee for study-specific milestones.
BOOST Awards - for junior investigators
PROPEL Awards - for established investigators
Any Johns Hopkins University faculty member interested
in funding for a new or ongoing clinical research project is eligible
For questions, contact Shernice Madison at email@example.com.
No application deadline
The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.
The ability to image alpha-synuclein deposition
in the brain would be a game-changing achievement for the Parkinson's
disease (PD) field. The accumulation of aggregated alpha-synuclein is
a pathological hallmark of PD and a priority target for drug development
given its hypothesized contribution to neurodegeneration. In vivo imaging
of alpha-synuclein pathology could be useful as a biomarker of the presence
of disease and disease progression and as a pharmacodynamic tool for
drug development. With this prize, the Foundation seeks to attract research
teams and accelerate momentum to speed the development of such a tracer.
Contestants: Anyone is eligible for
the prize who agrees to all contest rules. Contestants may be MJFF funded
or not and can be from either academia or industry.
Criteria for winning: The winning contestant
must demonstrate that the radiotracer binds with relatively high selectivity
to alpha-synuclein according to pre-specified criteria and must demonstrate
proof-of-concept in human subjects, including people with Parkinson's
disease and/or another synucleinopathy. See below for more details on
Timeline: There is no deadline
for submissions. The $2 million award will be issued to the first
contestant who submits compelling evidence of a viable selective tracer
and agrees to its widespread use.